These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15445940)

  • 1. Antibody response and survival after booster injections of poliomyelitis vaccine.
    BATSON R; CHRISTIE A; CHEATHAM WJ; MICHAL ML; SLEIGHT GW
    Clin Med (Northfield); 1962 Nov; 69():2495-7. PubMed ID: 15445940
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody response and survival following booster injections of poliomyelitis (killed-virus) vaccine.
    BATSON R; CHRISTIE A; CHEATHAM WJ; MICHAL ML; SLEIGHT GW
    Pediatrics; 1962 Jan; 29():116-20. PubMed ID: 13865768
    [No Abstract]   [Full Text] [Related]  

  • 3. [ANTIBODY FORMATION AFTER 3 DOSES OF QUADRUPLE VACCINE INJECTION FOLLOWED BY TRIVALENT ORAL POLIOMYELITIS VACCINE].
    HENIGST W; MUELLER F
    Dtsch Med Wochenschr; 1965 Aug; 90():1502-6. PubMed ID: 14344415
    [No Abstract]   [Full Text] [Related]  

  • 4. IMMUNOLOGIC RESPONSE TO ORAL POLIOMYELITIS VACCINE.
    ANDELMAN SL
    IMJ Ill Med J; 1963 Aug; 124():131-3. PubMed ID: 14046358
    [No Abstract]   [Full Text] [Related]  

  • 5. [SERUM PROTEIN PICTURE AND BLOOD GAMMA GLOBULIN LEVEL IN IMMUNIZATION AGAINST POLIOMYELITIS].
    FRATTINI JF
    Rev Sanid Milit Argent; 1963; 62():95-100. PubMed ID: 14175429
    [No Abstract]   [Full Text] [Related]  

  • 6. [ANTIBODY RESPONSE TO CONCENTRATED AND PURIFIED ANTI-POLIOMYELITIS VACCINE].
    BRANCATO P; PICCIOTTO L
    Riv Ist Sieroter Ital; 1963; 38():186-93. PubMed ID: 14084460
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of roosters in the antigenicity testing of Salk poliomyelitis vaccine.
    FURESZ J; MOREAU P
    J Immunol; 1963 Feb; 90():192-200. PubMed ID: 13945854
    [No Abstract]   [Full Text] [Related]  

  • 8. [VACCINATION WITH LIVER POLIOMYELITIS VACCINE (SABIN). VIROLOGICAL AND SEROLOGICAL CONTROL OF MASS VACCINATIONS PERFORMED IN THE CZECHOSLOVAKIAN SSR DURING 1958-59 AND IN 1960].
    ZACEK K; ADAM E; ADAMOVA V; BURIAN V; REZACOVA D; SKRIDLOVSKA E; VANECKOVA N; VONKA V
    Cas Lek Cesk; 1963 Nov; 102():1257-68. PubMed ID: 14111749
    [No Abstract]   [Full Text] [Related]  

  • 9. IMMUNIZATION AGAINST POLIOMYELITIS.
    DANE DS
    Br J Clin Pract; 1963 Nov; 17():631-8. PubMed ID: 14086502
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antibody response of infants to a "booster" dose of the Salk type of poliomyelitis vaccine given from 5 to 6 months after early primary immunization].
    MORRONE G; NUNZIATA B
    Pediatria (Napoli); 1961; 69():851-6. PubMed ID: 14476315
    [No Abstract]   [Full Text] [Related]  

  • 11. [SEROLOGICAL SURVEY OF CHILDREN FOR ANTIBODIES TO POLIOMYELITIS VIRUSES IN MOSCOW IN 1962].
    VOROSHILOVA MK; TARANOVA GP; EMELIANENKOVA VP; SHCHEGLOVA AP; KAPLAN SB
    Vopr Virusol; 1963; 29():404-9. PubMed ID: 14071275
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5-6-year-old children after primary vaccination and first booster with a pentavalent combined acellular pertussis vaccine: immunogenicity and tolerance of a tetravalent combined acellular pertussis vaccine given as a second booster.
    Mallet E; Matisse N; Mathieu N; Langue J; Boisnard F; Soubeyrand B;
    Vaccine; 2004 Mar; 22(11-12):1415-22. PubMed ID: 15063564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Present approach to immunization for poliomyelitis.
    GITHENS JH
    J Ky Med Assoc; 1963 Jun; 61():494-7. PubMed ID: 13948238
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [VACCINATION METHODS AND IMMUNIZATION AGAINST POLIOMYELITIS].
    LEPINE P
    Arch Ital Sci Med Trop Parassitol; 1964 Aug; 45():391-414. PubMed ID: 14212901
    [No Abstract]   [Full Text] [Related]  

  • 16. [ON HETEROLOGOUS ANTIBODY FORMATION AFTER ORAL POLIOMYELITIS VACCINATION].
    SCHMIDT J; NAUMANN G
    Z Immunitats Allergieforsch; 1964 Jul; 127():64-74. PubMed ID: 14259857
    [No Abstract]   [Full Text] [Related]  

  • 17. [Formation of neutralizing antibodies after the administration of combined poliomyelitis, diphtheria and tetanus vaccine].
    HENIGST W
    Munch Med Wochenschr; 1963 Jun; 105():1205-9. PubMed ID: 13953727
    [No Abstract]   [Full Text] [Related]  

  • 18. A ONE-DOSE POTENCY TEST FOR POLIOMYELITIS VACCINE.
    VANFRANK RM; HAVENS ML; MACFARLANE JO; BOAND AV; KIRK BE; HOSLEY RJ
    J Immunol; 1965 Apr; 94():475-81. PubMed ID: 14299018
    [No Abstract]   [Full Text] [Related]  

  • 19. TRIVALENT ORAL POLIO VACCINE: CLINICAL TRIAL OF A NEW FORMULATION.
    BURKE DM; GOW RC
    Clin Pediatr (Phila); 1963 Sep; 2():517-20. PubMed ID: 14047178
    [No Abstract]   [Full Text] [Related]  

  • 20. POLIO IMMUNIZATION.
    CROIELL LL; RICHARDSON FM
    Med Sci; 1964 Feb; 15():67-81. PubMed ID: 14118942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.